Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000188375 | SCV000241987 | pathogenic | not provided | 2025-01-24 | criteria provided, single submitter | clinical testing | De novo variant with or without confirmed parentage in patients with epilepsy previously tested at GeneDx (PMID: 29655203); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 29655203) |
Labcorp Genetics |
RCV003621515 | SCV004551796 | pathogenic | Developmental and epileptic encephalopathy, 9 | 2023-11-18 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln619*) in the PCDH19 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PCDH19 are known to be pathogenic (PMID: 21053371). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with epilepsy and neurodevelopmental disorder (PMID: 29655203). ClinVar contains an entry for this variant (Variation ID: 206338). For these reasons, this variant has been classified as Pathogenic. |